210 related articles for article (PubMed ID: 21441474)
21. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
22. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells.
Doehle BP; Hladik F; McNevin JP; McElrath MJ; Gale M
J Virol; 2009 Oct; 83(20):10395-405. PubMed ID: 19706707
[TBL] [Abstract][Full Text] [Related]
24. Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages.
Zheng N; Fujiwara M; Ueno T; Oka S; Takiguchi M
J Virol; 2009 Aug; 83(15):7668-77. PubMed ID: 19457989
[TBL] [Abstract][Full Text] [Related]
25. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
26. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
Yu J; Liang C; Liu SL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
[TBL] [Abstract][Full Text] [Related]
27. Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection.
Rabi SA; O'Connell KA; Nikolaeva D; Bailey JR; Jilek BL; Shen L; Page KR; Siliciano RF; Blankson JN
J Virol; 2011 Jan; 85(2):979-86. PubMed ID: 21068257
[TBL] [Abstract][Full Text] [Related]
28. Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.
Yue L; Pfafferott KJ; Baalwa J; Conrod K; Dong CC; Chui C; Rong R; Claiborne DT; Prince JL; Tang J; Ribeiro RM; Cormier E; Hahn BH; Perelson AS; Shaw GM; Karita E; Gilmour J; Goepfert P; Derdeyn CA; Allen SA; Borrow P; Hunter E
PLoS Pathog; 2015 Jan; 11(1):e1004565. PubMed ID: 25569444
[TBL] [Abstract][Full Text] [Related]
29. T-cell exhaustion in HIV infection.
Fenwick C; Joo V; Jacquier P; Noto A; Banga R; Perreau M; Pantaleo G
Immunol Rev; 2019 Nov; 292(1):149-163. PubMed ID: 31883174
[TBL] [Abstract][Full Text] [Related]
30. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.
Bermejo M; López-Huertas MR; García-Pérez J; Climent N; Descours B; Ambrosioni J; Mateos E; Rodríguez-Mora S; Rus-Bercial L; Benkirane M; Miró JM; Plana M; Alcamí J; Coiras M
Biochem Pharmacol; 2016 Apr; 106():30-45. PubMed ID: 26851491
[TBL] [Abstract][Full Text] [Related]
31. Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.
Veenhuis RT; Kwaa AK; Garliss CC; Latanich R; Salgado M; Pohlmeyer CW; Nobles CL; Gregg J; Scully EP; Bailey JR; Bushman FD; Blankson JN
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232278
[TBL] [Abstract][Full Text] [Related]
32. CD8+ cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines.
Mosoian A; Teixeira A; Caron E; Piwoz J; Klotman ME
Viral Immunol; 2000; 13(4):481-95. PubMed ID: 11192295
[TBL] [Abstract][Full Text] [Related]
33. The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons.
Esmail H; Riou C; Bruyn ED; Lai RP; Harley YXR; Meintjes G; Wilkinson KA; Wilkinson RJ
Annu Rev Immunol; 2018 Apr; 36():603-638. PubMed ID: 29490165
[TBL] [Abstract][Full Text] [Related]
34. Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.
Cunyat F; Rainho JN; West B; Swainson L; McCune JM; Stevenson M
J Virol; 2016 Jul; 90(14):6255-6262. PubMed ID: 27122585
[TBL] [Abstract][Full Text] [Related]
35. The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration.
Porcellini S; Alberici L; Gubinelli F; Lupo R; Olgiati C; Rizzardi GP; Bovolenta C
Blood; 2009 Apr; 113(15):3443-52. PubMed ID: 19211937
[TBL] [Abstract][Full Text] [Related]
36. HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis.
Williams KC; Burdo TH
APMIS; 2009 May; 117(5-6):400-12. PubMed ID: 19400864
[TBL] [Abstract][Full Text] [Related]
37. Why is HIV a pathogen?
Forsman A; Weiss RA
Trends Microbiol; 2008 Dec; 16(12):555-60. PubMed ID: 18977141
[TBL] [Abstract][Full Text] [Related]
38. Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.
Reuter MA; Pombo C; Betts MR
Cytokine Growth Factor Rev; 2012; 23(4-5):181-91. PubMed ID: 22743036
[TBL] [Abstract][Full Text] [Related]
39. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
40. CD8
Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
